These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32270883)

  • 1. Clinical performance of Determine HBsAg 2 rapid test for Hepatitis B detection.
    Avellon A; Ala A; Diaz A; Domingo D; Gonzalez R; Hidalgo L; Kooner P; Loganathan S; Martin D; McPherson S; Munoz-Chimeno M; Ryder S; Slapak G; Ryan P; Valbuena M; Kennedy PT
    J Med Virol; 2020 Dec; 92(12):3403-3411. PubMed ID: 32270883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia.
    Chisenga CC; Musukuma K; Chilengi R; Zürcher S; Munamunungu V; Siyunda A; Ojok D; Bauer S; Wandeler G; Vinikoor M;
    J Clin Virol; 2018 Jan; 98():5-7. PubMed ID: 29175231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes.
    Scheiblauer H; El-Nageh M; Diaz S; Nick S; Zeichhardt H; Grunert HP; Prince A
    Vox Sang; 2010 Apr; 98(3 Pt 2):403-14. PubMed ID: 20412171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay.
    Shen L; Zhang Y; Shi M; Shao L; Feng S; Li W; Fang Z; Yin J; Li T
    J Med Virol; 2024 Jul; 96(7):e29817. PubMed ID: 39034740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity.
    Lin YH; Wang Y; Loua A; Day GJ; Qiu Y; Nadala EC; Allain JP; Lee HH
    J Clin Microbiol; 2008 Oct; 46(10):3319-24. PubMed ID: 18701669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
    Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
    J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania.
    Franzeck FC; Ngwale R; Msongole B; Hamisi M; Abdul O; Henning L; Letang E; Mwaigomole G; Battegay M; Hatz C; Tanner M
    PLoS One; 2013; 8(3):e58468. PubMed ID: 23469281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study.
    Ségéral O; N'Diaye DS; Prak S; Nouhin J; Chhun S; Khamduang W; Chim K; Roque-Afonso AM; Piola P; Borand L; Ngo-Giang-Huong N; Rouet F;
    J Clin Virol; 2018 Dec; 109():29-34. PubMed ID: 30388664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.
    Matsumoto A; Tanaka E; Morita S; Yoshizawa K; Umemura T; Joshita S
    J Gastroenterol; 2012 Sep; 47(9):1006-13. PubMed ID: 22370816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
    Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
    Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana.
    Mutocheluh M; Owusu M; Kwofie TB; Akadigo T; Appau E; Narkwa PW
    BMC Res Notes; 2014 Dec; 7():873. PubMed ID: 25475050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samples.
    Hirzel C; Pfister S; Gorgievski-Hrisoho M; Wandeler G; Zuercher S
    J Clin Virol; 2015 Aug; 69():33-5. PubMed ID: 26209374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection.
    Murayama A; Momose H; Yamada N; Hoshi Y; Muramatsu M; Wakita T; Ishimaru K; Hamaguchi I; Kato T
    J Clin Virol; 2019 Aug; 117():37-42. PubMed ID: 31176210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations.
    Chevaliez S; Challine D; Naija H; Luu TC; Laperche S; Nadala L; Allain JP; Lee HH; Pawlotsky JM
    J Clin Virol; 2014 Feb; 59(2):89-93. PubMed ID: 24355522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upconverting nanoparticle reporter-based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigen.
    Martiskainen I; Talha SM; Vuorenpää K; Salminen T; Juntunen E; Chattopadhyay S; Kumar D; Vuorinen T; Pettersson K; Khanna N; Batra G
    Anal Bioanal Chem; 2021 Feb; 413(4):967-978. PubMed ID: 33230700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples.
    Servant-Delmas A; Mercier-Darty M; Ly TD; Wind F; Alloui C; Sureau C; Laperche S
    J Clin Virol; 2012 Apr; 53(4):338-45. PubMed ID: 22296790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial and performance evaluation of the Wantai HBsAg (CMIA) diagnostic kit for screening blood donors in China.
    Chen J; Wang F; Li J; Zuo Q; Wu D; Xiao C
    Sci Rep; 2024 Feb; 14(1):1891. PubMed ID: 38307913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.